Fang Wang, Ph.D, RPhT,

***** ******** **.

Indianapolis, IN 46234

Phone: 317-***-**** (h)

317-***-**** (c)

ab1fmx@r.postjobfree.com

Objective

To pursue a pharmacy technician position where I can make invaluable contributions

Occupational Licenses & Certificates

National CPhT certification through the Pharmacy Technician Certification Board (issued

on Dec 2012)

Licensed with the Indiana State Board of Pharmacy and in good standing (issued on

Jan 2013)

Knowledge, Skills, Abilities & Behaviors

*Extensive compounding aseptic preparation, high-risk compounding techniques.

*Fill prescription orders by making ophthalmic solution, inhalation and other IV/infusion

products using compounding aseptic isolator or laminar air flow hood.

*Quality Control of pharmaceutical IV/ infusion products, including sterility testing and

potency testing using UV visible spectrophotometer.

* Basic computer skills, including fundamental knowledge of Windows based software programs,

including but not limited to word processing and spreadsheet applications

* Ability to communicate, perform and comprehend variables within the pharmacy operation

* * Ability to adhere to regulatory and company compliance, Code of Conduct and Business Ethics

(OSHA,DEA, State Board of Pharmacy, etc.)

* Keeps abreast of current state, federal and company policies, procedures and regulations

* Ability to accept ownership and accountability for the successful completion all pharmacy

production duties and tasks and achievement of pharmacy branch goals

* Understand, promote and comply with rules and regulations governing residents' rights

* Organization skills including the ability to prioritize and manage multiple tasks in a dynamic

environment

* Ability to effectively and harmoniously interact with facility, group, division and company

management and other employees at all levels; promotes teamwork and demonstrates strong

professionalism.Ability to work and produce results under pressure.

Additional Abilities

1. Molecular Biology (Northern blot,Making expression constructs,Gene silencing using

siRNA,PCR, RT-PCR)

2. Protein Biochemistry and Purification Techniques(SDS-PAGE, gelatin zymography,

western blot, ELISA and co-IP,UV cross-linking and gel mobility shift assay)

3. Cell Biology(Cell lines and tissue culture,Immunohistochemistry, fluorescence

microscopic analysis,Cytotoxicity assay, apoptosis study).

4. Animal surgeries (Tail injections of mice, Cannulation of jugular veins of rats,

Implantation of tumor cells in mice).

Employment History

Clinical Pharmacy Technician

04/2013-current Pharmakon Pharmaceutical Inc Carmel, IN

Extensive IV / Infusion experience, Extensive compounding aseptic preparation,

high-risk compounding techniques.

Quality Control of pharmaceutical IV/ infusion products, including sterility testing

and potency testing using UV visible spectrophotometer.

Postdotoral fellow

01/2007 - 02/2012 IUPUI Indianapolis, IN

Design of small molecules and proteins for the purpose of altering cellular processes

and developing new anti-cancer therapeutics; Particularly, of modulating the signaling

pathway mediated by cell surface receptors that play critical role in tumor invasion and

metastasis.

Postdoctoral Fellow

04/2004 - 01/2007 UTHSC Memphis,TN

Study of the role of NF-қB in TGF-β1-induced Apoptosis of Hepatocytes.

Education and Training

Completion Date Issuing Institution Qualification Course of Study

07/2003 Peking Union Medical College Doctorate Degree Pharmacology

07/2000 Henan Medical University Master Degree Pharmacology

07/1997 Henan Medical University Bachelor Degree Pharmacy

Honors & Activities

Publications

1. Peng, X., Wang, F., Li, L., Bumerdene, K., Wang, B., Sinn, T., Pollok, K., Jalal, S., Hanna,

N., Turchi, J. J., Lang, L., SIu, H., and Meroueh, S. O. (2012) Exploring Polypharmacology

for Drug Repurposing: Docking of Approved Drugs to the Human Structural Genome,

Patient Records Mining, Cellular and In Vivo Studies in Lung Cancer Mol. Syst.

Biol. Submitted.

2. Mani, T., Wang, F., Knabe, W. E., Sinn, A. L., Khanna, A., Jo, I., Li, J., Silver, J. M.,

Sandusky, G., Sledge, C. B., Jones, D. R., Khanna, R., Pollock, K. E., and Meroueh, S. O.

(2012) A Small Molecule Inhibitor of Protein-Protein Interactions of the Urokinase Receptor

Impairs Breast Tumor Metastasis, J. Med. Chem. submitted.

3. Wang F, Eric Knabe W, Li L, Jo I, Mani T, Roehm H, Oh K, Li J, Khanna M, Meroueh SO.

Design, synthesis, biochemical studies, cellular characterization, and structure-based

computational studies of small molecules targeting the urokinase receptor. Bioorg Med

Chem. 2012 Aug 1;20(15):4760-73. doi: 10.1016/j.bmc.2012.06.002. Epub 2012 Jun 12.

4. Wang F, Li J, Sinn AL, Knabe WE, Khanna M, Jo I, Silver JM, Oh K, Li L,

Sandusky GE, Sledge GW, Nakshatri H, Jones DR, Pollok KE,

MerouehSO.Virtual screening targeting the urokinase receptor, biochemical and

cell-based studies, synthesis, pharmacokinetic characterization, and effect on

breast tumor metastasis.J Med Chem. 2011 Oct 27;54(20):7193-205. Epub 2011

Oct 4.

Khanna M, Wang F, Jo I, Knabe WE, Wilson SM, Li L, Bum-Erdene K, Li J, W

5.

Sledge G, Khanna R, Meroueh SO. Targeting multiple conformations leads to

small molecule inhibitors of the uPAR uPA protein-protein interaction that block

cancer cell invasion.ACSChem Biol. 2011 Nov 18;6(11):1232-43. Epub 2011 Sep

29.

Li, L., Khanna, M., Jo, I., Wang, F. and Meroueh, S. O. (2011) Target-Specific

6.

Support Vector Machine Scoring in Structure-Based Virtual Screening:

Computational Validation, in Vitro Testing in Kinases, and Effects on Lung Cancer

Cell Proliferation. J ChemInf Model, 2011 Mar 25

Fang Wang, SwayamjotKaur, Lakita G. Cavin, Marcello Arsura. Nuclear-factor-

7.

kB (NF-kB) and radical oxygen species play contrary roles in transforming growth

factor-b1 (TGF-b1)-induced apoptosis in hepatocellular carcinoma (HCC) cells.

Biochemical and Biophysical Research Communications 2008, 377: 1107-12

Cavin LG, Wang F, Factor VM, Kaur S, Venkatraman M, Thorgeirsson SS,

8.

ArsuraM.Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-

induced apoptosis through activation of nuclear factor-kappaB in murine

hepatocellular carcinomas. Mol Cancer Res. 2005 Jul; 3(7):403-12

SwayanjotKaur, Fang Wang, ManickamVenkatraman, Marcello Arsura. X-linked

9.

inhibitor of apoptosis protein (XIAP) inhibits c-Jun N-ternimal kinase (JNK1)

activation by Transforming Growth Factor-β1 (TGF-β1) through Ubiquitin-

mediated proteosomal degradation of TGFβ1-activated kinase 1 (TAK1). J Biol

Chem.2005 Nov 18; 280(46):38599-608. Epub 2005 Sep

Wang F, Cao Y, Zhao W, Liu H, Fu Z, Han R.Taxol inhibits melanoma metastases

10.

through apoptosis induction, angiogenesis inhibition, and restoration of E-

cadherin and nm23 expression. J Pharmacol Sci. 2003 Oct; 93(2):197-203

Fang Wang, Yu Cao, HongYan Liu, ShaoFengXu and Rui Han. The anti-invasion

11.

and anti-angiogenesis effects of taxol and camptothecin on melanoma cells. [J]

Journal of Asian Natural Products Research, 2003, 5(2): 121-129

Fang Wang, Rui Han. Development of research for drug-resistance mechanism

12.

of taxol. [J]. Chinese Journal of Cancer, 2002, 21 (4): 439-442

13. Fang Wang, Yu Cao, ZhaoDi FU, KaiFeng Wang, Rui Han. The anti-oxidation

effect of Ren Zhu particles. [J] Chinese Journal of Modern ClinicalMedicine, 2002

Nov, 1(1): 39-41

14. Fang Wang, Yu Cao, HongYan Liu, ZhaoDi FU, Rui Han. Experimental studies

on the apoptosis of HL-60 cells induced by Bruceajavanica oil emulsion. [J]

ZhongguoZhong Yao ZaZhi. 2003, 28(8):759~762

15. Cao Y, Wang F, Liu HY, Fu ZD, Han R.Resveratrol induces apoptosis and

differentiation in acute promyelocytic leukemia (NB4) cells. J Asian Nat Prod

Res. 2005 Aug;7(4):633-41.

16. Cao Y, Fu ZD, Wang F, Liu HY, Han R.Anti-angiogenic activity of resveratrol, a

natural compound from medicinal plants. J Asian Nat Prod Res. 2005

Jun;7(3):205-13.

Contact this candidate